AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among: PROTEON THERAPEUTICS, INC., a Delaware corporation; REM 1 ACQUISITION, INC., a Delaware corporation; and ARTARA THERAPEUTICS, INC. a Delaware corporation Dated as of September 23, 2019Merger Agreement • September 24th, 2019 • Proteon Therapeutics Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledSeptember 24th, 2019 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this "Agreement") is made and entered into as of September 23, 2019, by and among PROTEON THERAPEUTICS, INC., a Delaware corporation ("Parent"), REM 1 Acquisition, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Proteon Merger Sub"), and ARTARA THERAPEUTICS, INC., a Delaware corporation (the "Company"). Certain capitalized terms used in this Agreement are defined in Exhibit A.
FORM OF SUPPORT AGREEMENTSupport Agreement • September 24th, 2019 • Proteon Therapeutics Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledSeptember 24th, 2019 Company Industry JurisdictionThis SUPPORT AGREEMENT (this “Agreement”) is entered into as of September 23, 2019, among, Proteon Therapeutics, Inc., a Delaware corporation (“Parent”), ArTara Therapeutics, Inc., a Delaware corporation (“Company”) and the undersigned (the “Stockholder”).